During the past decade, Chan Heart Rhythm Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chan Heart Rhythm Institute" are "Heart Failure" (6 trials), "CHF" (2 trials), "Chronic Heart Disease" (2 trials), "Congestive Heart Failure" (2 trials) and "Diastolic Heart Failure" (1 trials). Many other conditions were trialed in "Chan Heart Rhythm Institute" in a lesser frequency.

Most popular intervention types in "Chan Heart Rhythm Institute" are "Device" (7 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BAROSTIM NEO® System" (1 trials), "BATwire Implant Kit" (1 trials), "Barostim™ System" (1 trials), "Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System" (1 trials) and "Medical Management" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chan Heart Rhythm Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Chan Heart Rhythm Institute". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chan Heart Rhythm Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chan Heart Rhythm Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".